Maria Łaciak

Genetically modified tumour vaccines (GMTV) in melanoma clinical trials

Sergiusz Nawrocki, P. Murawa, Julian Malicki et al. · Immunology Letters · 2000 · 29 citations

Medicine, Immunology, Oncology +14

Soluble human interleukin‐6‐receptor modulates interleukin‐6‐dependent <i>N</i>‐glycosylation of α₁‐protease inhibitor secreted by HepG2 cells

A Mackiewicz, Stefan Rose‐John, Heidi Schooltink et al. · FEBS Letters · 1992 · 29 citations

Life Sciences, Biochemistry, Molecular Biology +17

Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

Andrzej Maćkiewicz, Jacek Mackiewicz, Piotr J. Wysocki et al. · Expert Opinion on Investigational Drugs · 2012 · 27 citations

Medicine, Immunology, Oncology +17

Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma

Jacek Mackiewicz, A. Karczewska-Dzionk, Maria Łaciak et al. · Medicine · 2015 · 20 citations · Full text

Medicine, Immunology, Oncology +17

C-reactive protein and α-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs

Wacław Majewski, A. Zieliński, Maria Łaciak et al. · European Journal of Vascular Surgery · 1993 · 15 citations

Medicine, Surgery, Clinical Biochemistry +12